The Gore SCAFFOLD Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.

Also called NCT01901874

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 312 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01901874
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01901874. Allocation not applicable; no masking; primary purpose treatment. Start 2013-07 (actual); primary completion 2017-12 (actual). Results posted on 2019-05-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Gore SCAFFOLD Clinical Study
Condition
Carotid Artery Disease
Condition
Carotid Artery Stenosis
Intervention (Device)
Carotid Artery Stenting
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct01901874
Content hash
20165ea4bff3b02dac90e89ab70f30993881aca1ce773f4daac42bda8f3d6e67